Research Article
Clinical Observation of Fuzheng Xiaoji Granule in the Treatment of Stage IIIC Colorectal Cancer
Table 1
Basic characteristics of patients.
| | Characteristic | Control group (n = 50) | Treatment group (n = 100) | value |
| | Sex | — | — | — | | Male | 37 (74%) | 64 (64%) | 0.218 | | Female | 13 (26%) | 36 (36%) | — |
| | Age, years | — | — | — | | Mean ± SD | 63.14 ± 12.45 | 63.30 ± 12.90 | 0.942 |
| | Primary site | — | — | — | | Colon | 43 (86%) | 78 (78%) | 0.242 | | Rectum | 7 (14%) | 22 (22%) | — |
| | Adjuvant chemotherapy | — | — | — | | XELOX | 43 (86%) | 91 (91%) | 0.350 | | FOLFOX | 7 (14%) | 9 (9%) | — |
| | ECOG performance status | — | — | — | | 0 | 19 (38%) | 29 (29%) | 0.060 | | 1 | 25 (50%) | 67 (67%) | — | | 2 | 6 (12%) | 4 (4%) | — |
|
|
